Southern Iran-based Qeshm Micro Algae Biological Refinery (QMAB), the Middle-East’s largest microalgae biological technological company, has started negotiations with worldwide airlines to provide them with long term bio-jet agreements, in coordination with the Kyoto protocol CO2 reduction requirements.
Employing a patented high-lipid local species Nannochloropsis, QMAB has achieved a high production rate of about 240 t/h/y with more than 50% oil, enabling QMAB to produce biofuel from microalgae economic, according to the company.
Qeshm Microalgae Biorefinery is located on 1000 hectares of land on Qeshm Island, the largest island in the Persian Gulf. The island, which has a 300 square kilometer free zone jurisdiction, is 135 km long, and lies strategically in the Strait of Hormuz, 60 kilometers from the Omani port of Khasab, and about 180 kilometers from the UAE Port Rashid.
The privately held company’s strong background in scientific research is built around professor Nasrin Moazami’s, QMAB’s Scientific Consultant, who serves as head of their R&D center. Moazami brings to QMAB more than 15 years of biotech experience and high-level relationships with international biotech societies and organizations.
QMAB also produces medical and sanitary products for industrial purposes. The company aims to enrich foods for human health, and to contribute to a healthy world by reducing greenhouse gases and producing healthy biological products.
Photo caption: QMAB has achieved a production rate of about 240 t/h/y with more than 50% oil.
Reprinted with permission from Algae Industry Magazine